Price $11.10 |
Market Cap
484.5M
|
Sector Health Care |
Div. Growth
-
|
|
P/E
51.9
|
P/B
8.58
|
P/S
0.54
|
Dividend %
-
|
|
P/CF
39.6
|
P/FCF
6.0
|
Op. Cash Flow
90.4K
|
FCF
1.7
|
|
Op. Margin
5.30%
|
Net Margin
1.00%
|
ROE
19.70%
|
ROI
5.00%
|
|
ROA
1.10%
|
EPS Growth
-18.70%
|
Current Ratio
1.4
|
Debt/Equity
-
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| CRYO-CELL International, Inc. (CCEL) | $6.75 | - | - | 47.9M | Strong Buy |
| Aviragen Therapeutics Inc (AVIR) | $0.65 | - | - | 24.3M | Strong Buy |
| Misonix, Inc. (MSON) | $10.20 | - | - | 91.7M | Strong Buy |
| Dyadic International, Inc. (DYAI) | $1.46 | - | - | 42.8M | Strong Buy |
| Bioanalytical Systems, Inc. (BASI) | $1.76 | - | - | 12.6M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
